SW
BMY.RT

SVB Wealth’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

SVB Wealth’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,677
Closed -$20K – 973
2020
Q4 		$20K Sell
28,677
-6,367
-18% -$13.6K ﹤0.01% 836
2020
Q3 		$79K Sell
35,044
-1,502
-4% -$4.29K ﹤0.01% 689
2020
Q2 		$131K Sell
36,546
-8,430
-19% -$30.4K ﹤0.01% 566
2020
Q1 		$171K Sell
44,976
-1,645
-4% -$5.42K ﹤0.01% 473
2019
Q4 		$140K Buy
+46,621
New +$121K ﹤0.01% 590

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

SVB Wealth's BMY.RT Position: Q1 2021 in Review

SVB Wealth sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 28,677 shares — an estimated $20K sold.

SVB Wealth first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $171K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • SVB Wealth reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • SVB Wealth sold 28,677 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $20K.
  • SVB Wealth first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • SVB Wealth's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $171K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on SVB Wealth's 13F filing for Q1 2021, filed 11 May 2021.